ATE297412T1 - Dermatandisulfat,ein hemmer von thrombinerzeugung und komplementaktivierung - Google Patents

Dermatandisulfat,ein hemmer von thrombinerzeugung und komplementaktivierung

Info

Publication number
ATE297412T1
ATE297412T1 AT97936042T AT97936042T ATE297412T1 AT E297412 T1 ATE297412 T1 AT E297412T1 AT 97936042 T AT97936042 T AT 97936042T AT 97936042 T AT97936042 T AT 97936042T AT E297412 T1 ATE297412 T1 AT E297412T1
Authority
AT
Austria
Prior art keywords
dermatan
complement activation
thrombin generation
disulphate
inhibitor
Prior art date
Application number
AT97936042T
Other languages
English (en)
Inventor
Gorp Cornelius L Van
Stephanie J Brister
Michael R Buchanan
Robert J Linhardt
Original Assignee
Celsus Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25164665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE297412(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Celsus Biopharmaceuticals Inc filed Critical Celsus Biopharmaceuticals Inc
Application granted granted Critical
Publication of ATE297412T1 publication Critical patent/ATE297412T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/06—Use of macromolecular materials
    • A61L33/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97936042T 1997-02-06 1997-07-03 Dermatandisulfat,ein hemmer von thrombinerzeugung und komplementaktivierung ATE297412T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/795,099 US5922690A (en) 1996-04-25 1997-02-06 Dermatan disulfate, an inhibitor of thrombin generation and activation
PCT/US1997/011750 WO1998034959A1 (en) 1997-02-06 1997-07-03 Dermatan disulfate, an inhibitor of thrombin generation and complement activation

Publications (1)

Publication Number Publication Date
ATE297412T1 true ATE297412T1 (de) 2005-06-15

Family

ID=25164665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97936042T ATE297412T1 (de) 1997-02-06 1997-07-03 Dermatandisulfat,ein hemmer von thrombinerzeugung und komplementaktivierung

Country Status (10)

Country Link
US (1) US5922690A (de)
EP (1) EP0983304B1 (de)
JP (1) JP2003512807A (de)
AT (1) ATE297412T1 (de)
AU (1) AU734112C (de)
CA (1) CA2279535C (de)
DE (1) DE69733493T2 (de)
ES (1) ES2242980T3 (de)
PT (1) PT983304E (de)
WO (1) WO1998034959A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
IL127826A0 (en) * 1998-12-29 1999-10-28 Laster Gail Restenosis drug therapy
DE19913707A1 (de) 1999-03-26 2000-10-05 Privates Inst Bioserv Gmbh Immunadsorber zur Sepsistherapie
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
KR20020032444A (ko) * 1999-06-30 2002-05-03 잭 허쉬 응괴 연관된 응고 인자를 억제하는 헤파린 조성물
US6518244B2 (en) * 2000-03-09 2003-02-11 Intimax Corporation Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof
JP2002080371A (ja) * 2000-06-23 2002-03-19 Seikagaku Kogyo Co Ltd プラスミノーゲンアクチベーター活性促進剤
PL363047A1 (en) * 2000-09-08 2004-11-15 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
AU2002243630A1 (en) 2001-01-23 2002-08-06 Massachusetts Institute Of Technology Solid- and solution -phase synthesis of heparin and other glycosaminoglycans
JP4915888B2 (ja) * 2001-08-01 2012-04-11 株式会社ジャパンエコロジーシンキング 豚皮抽出物よりのデルマタン硫酸の製造方法
DE10307205A1 (de) * 2003-02-20 2004-09-09 Jostra Ag Blutverträgliche Beschichtung von Kunststoffoberflächen
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
US20090105463A1 (en) * 2005-03-29 2009-04-23 Massachusetts Institute Of Technology Compositions of and Methods of Using Oversulfated Glycosaminoglycans
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US20080279909A1 (en) * 2006-05-12 2008-11-13 Cleek Robert L Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8703136B2 (en) 2006-10-10 2014-04-22 Regenesance B.V. Complement inhibition for improved nerve regeneration
US8617820B2 (en) * 2007-08-28 2013-12-31 Ortho-Clinical Diagnostics, Inc. Use of glycosaminoglycans to reduce non-specific binding in immunoassays
DE102008045127A1 (de) 2008-09-01 2010-03-04 Heinrich, Hans-Werner, Prof. Dr. Filtersystem zur extrakorporalen Abreicherung von aktivierten Polymorphkernigen Granuloyzten (Polymorphonuclear leukocytes-PMNs)
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
EP3375462B1 (de) 2011-03-11 2023-06-07 W. L. Gore & Associates, Inc. Verbesserungen an immobilisierten biologischen einheiten
WO2013006906A1 (en) * 2011-07-11 2013-01-17 Commonwealth Scientific And Industrial Research Organisation Dermatan sulphate, pharmaceutical compositions and process for producing same
CN106188341B (zh) * 2016-07-27 2019-09-17 河北常山生化药业股份有限公司 肝素钠下脚料制备高纯度硫酸皮肤素工艺
CN106146688A (zh) * 2016-07-27 2016-11-23 河北常山生化药业股份有限公司 肝素钠下脚料制备类肝素工艺
WO2021107067A1 (ja) * 2019-11-29 2021-06-03 マルホ株式会社 医薬品または化粧品用組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA795325A (en) * 1962-08-06 1968-09-24 Roussel-Uclaf Procede de preparation de nouveaux derives de l'heparine
SE306597B (de) * 1964-12-17 1968-12-02 Incentive Ab
FR2482603A1 (fr) * 1980-05-14 1981-11-20 Pharmindustrie Nouveaux esters d'heparine utilisables pour la preparation de medicaments, et procedes pour leur preparation
DE3124384C2 (de) * 1981-06-22 1985-05-15 Herbert Prof. Dr. 1000 Berlin Voß Dermatanpolysulfat, Verfahren zu dessen Herstellung und dieses enthaltendes virushemmendes Mittel
FR2538404B1 (de) * 1982-12-28 1985-08-23 Anic Spa
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US4745106A (en) * 1986-08-20 1988-05-17 Griffin Charles C Heparin derivatives having improved anti-Xa specificity
CA2000650A1 (en) * 1989-10-13 1991-04-13 Louis Jaques Product and process for the treatment and prevention of intravascular thrombi and atherosclerosis
US5362755A (en) * 1990-01-05 1994-11-08 Sepracor, Inc. Method for treating asthma using optically pure (R)-albuterol
JP2855307B2 (ja) * 1992-02-05 1999-02-10 生化学工業株式会社 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法

Also Published As

Publication number Publication date
AU734112C (en) 2002-03-28
WO1998034959A1 (en) 1998-08-13
EP0983304B1 (de) 2005-06-08
AU3880797A (en) 1998-08-26
ES2242980T3 (es) 2005-11-16
AU734112B2 (en) 2001-06-07
JP2003512807A (ja) 2003-04-02
CA2279535C (en) 2006-10-03
US5922690A (en) 1999-07-13
DE69733493T2 (de) 2006-03-23
CA2279535A1 (en) 1998-08-13
DE69733493D1 (de) 2005-07-14
EP0983304A1 (de) 2000-03-08
PT983304E (pt) 2005-09-30

Similar Documents

Publication Publication Date Title
ATE297412T1 (de) Dermatandisulfat,ein hemmer von thrombinerzeugung und komplementaktivierung
BR9711117A (pt) Oligossacarídios modificados.
IE881150L (en) Low molecular weight heparins of regular structure, their¹preparation and their biological uses
DE69103833D1 (de) Biologisch abbaubares gepfropftes Polysaccharid enthaltende Waschmittelzusammensetzung.
FR2538404B1 (de)
ES2021905A6 (es) Procedimiento para la preparacion de fracciones de sulfato de dermatano.
ES2161615A1 (es) Composiciones de heparinas de muy bajo peso molecular.
CA2253833A1 (en) Derivatives of k5 polysaccharide having high anticoagulant activity
SV2004001626A (es) Mezclas de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
PH25136A (en) Natural heparan sulphate and dermatan sulphate in substantially pure form and method of use thereof
TR199700924A2 (xx) Amfoterik polimerler i�eren bula��k makinesi bile�imi.
EP0424351A3 (en) Modified heparin cofactor ii
FI913201A (fi) Ymppolysackarider, deras framstaellningsfoerfarande och deras anvaendning som sekvesteringsagenter.
PT986580E (pt) Misturas de oligossacarideos com actividade antitrombotica
ATE157991T1 (de) Sulfatierte polysaccharide, verfahren zu deren herstellung, pharmazeutische zusammensetzung und ihre verwendung
MX9203786A (es) Glicosaminoglicuronano sulfatado con actividad antitrombotica
PL337356A1 (en) Highly transparent polymeric composition
AR006949A1 (es) Composicion detergente de lavanderia que comprende un agente tensioactivo, enzima lipasa y poliamina
WO2001015654A3 (fr) Polysaccharide antithrombotique de bas poids moleculaire
AU5833694A (en) Oligosaccharides having biological activity and preparation of same from glycosaminoglycans
ECSP972214A (es) Oligosacaridos modificados

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0983304

Country of ref document: EP

REN Ceased due to non-payment of the annual fee